Skip to main content
. 2021 Jun 23;54(2):469–477. doi: 10.4143/crt.2021.205

Fig. 1.

Fig. 1

CONSORT diagram. CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; EVE, everolimus.